Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...
WRAL9d
Weight loss pill could replace injections, would be transformative for millions
Many who would benefit from the drug find the idea of a weekly injection a turnoff. Novo Nordisk's recent announcement that Wegovy in a tablet proved as effective as the shots could open the ...
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...